First-Line Management of Primary Male Hypogonadism: Lifestyle Optimisation Before Testosterone Therapy
Primary male hypogonadism requires a structured first-line approach that addresses modifiable factors before pharmacological therapy is initiated. The initial step targets the clinical conditions that directly influence hormone levels.
Clinical Approach
Current evidence-based guidance prioritises lifestyle improvement and management of underlying comorbidities as the first step in treatment. In particular, weight reduction in patients with obesity plays a central role in restoring hormonal balance.
Treatment Goal
The primary clinical target is a significant increase in serum testosterone levels. Achieving this through initial lifestyle measures may reduce or defer the need for further intervention.
The complete structured regimen — including the specific sequence of interventions and criteria for escalation — is available in the full protocol.
References
- Improve lifestyle, reduce weight in case of obesity and treat comorbidities before starting testosterone therapy.
- In adult-onset hypogonadism testosterone treatment may improve symptoms, but many hypogonadal men are obese and have comorbidities: weight reduction, lifestyle modification and good treatment of comorbidities are more important than just testosterone treatment.
- Reduction of BMI in obese patients, for example, is associated with significant increase of serum testosterone levels.
View source ↗